63 related articles for article (PubMed ID: 1283470)
21. Phosphorylation of mouse thymocyte CD4 and CD8: regulation of surface expression.
Tagawa M; Koike T; Griffith LC
Biochem Int; 1991 Jul; 24(4):739-47. PubMed ID: 1799373
[TBL] [Abstract][Full Text] [Related]
22. Induction by human immunodeficiency viruses types 1 and 2 of degradation of CD4 but not of a CD4 mutant unable to bind viral envelope glycoproteins.
Cucchiarini M; Cagnon L; Giordanengo V; Doglio A; Lefebvre JC
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):427-36. PubMed ID: 7697438
[TBL] [Abstract][Full Text] [Related]
23. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
24. CD4 down-modulation by ganglioside and phorbol ester inhibits human herpesvirus 7 infection.
Yasukawa M; Inoue Y; Sada E; Yakushijin Y; Furukawa M; Fujita S
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2381-5. PubMed ID: 7561781
[TBL] [Abstract][Full Text] [Related]
25. The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: possible involvement of protein kinase C pathway.
Chowdhury IH; Koyanagi Y; Kobayashi S; Hamamoto Y; Yoshiyama H; Yoshida T; Yamamoto N
Virology; 1990 May; 176(1):126-32. PubMed ID: 1970444
[TBL] [Abstract][Full Text] [Related]
26. Differential human immunodeficiency virus expression in CD4+ cloned lymphocytes: from viral latency to replication.
Chapel A; Bensussan A; Vilmer E; Dormont D
J Virol; 1992 Jun; 66(6):3966-70. PubMed ID: 1374814
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation followed by re-expression of equine CD4 molecules in response to phorbol myristate acetate.
Zhang CH; Grünig G; Davis W; Antczak DF
Vet Immunol Immunopathol; 1994 Jul; 42(1):71-82. PubMed ID: 7975181
[TBL] [Abstract][Full Text] [Related]
28. Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells.
Fernie BF; Poli G; Fauci AS
J Virol; 1991 Jul; 65(7):3968-71. PubMed ID: 1710293
[TBL] [Abstract][Full Text] [Related]
29. MS-8209, a new Amphotericin B derivative that inhibits HIV-1 replication in vitro and restores T-cell activation via the CD3/TcR in HIV-infected CD4+ cells.
Céfai D; Hadida F; Jung M; Debre P; Vernin JG; Seman M
AIDS; 1991 Dec; 5(12):1453-61. PubMed ID: 1726040
[TBL] [Abstract][Full Text] [Related]
30. Rapid and reversible modulation of T4 (CD4) on monocytoid cells by phorbol myristate acetate: effect on HIV susceptibility.
Firestein GS; Reifler D; Richman D; Gruber HE
Cell Immunol; 1988 Apr; 113(1):63-9. PubMed ID: 3365771
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 associated down-modulation of CD4 gene expression is differentially restricted in lymphocytic and monocytic cell lines.
Geleziunas R; Bour S; Wainberg MA
J Leukoc Biol; 1994 May; 55(5):589-95. PubMed ID: 8182337
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans.
Pettoello-Mantovani M; Casadevall A; Kollmann TR; Rubinstein A; Goldstein H
Lancet; 1992 Jan; 339(8784):21-3. PubMed ID: 1370335
[TBL] [Abstract][Full Text] [Related]
33. The role and fate of the CD4 molecule in lymphocytes and monocytes infected by HIV-1.
Wainberg MA; Geleziunas R; Bour S
Braz J Med Biol Res; 1993 Feb; 26(2):123-36. PubMed ID: 7504965
[TBL] [Abstract][Full Text] [Related]
34. Misinterpretation in virus clearance studies of biological products due to an uncommon discrepancy between cytopathic effects and infectivity of human immunodeficiency virus (HIV).
Urayama T; Cameron R; Sato T; Yunoki M; Ikuta K
Biologicals; 2013 Mar; 41(2):125-7. PubMed ID: 23131459
[No Abstract] [Full Text] [Related]
35. Inactivation of the human immunodeficiency virus by hypericin: evidence for photochemical alterations of p24 and a block in uncoating.
Degar S; Prince AM; Pascual D; Lavie G; Levin B; Mazur Y; Lavie D; Ehrlich LS; Carter C; Meruelo D
AIDS Res Hum Retroviruses; 1992 Nov; 8(11):1929-36. PubMed ID: 1283309
[TBL] [Abstract][Full Text] [Related]
36. Suppression of HIV-1 reverse transcriptase activity by culture supernatants of mycoplasmas.
Shang H; Miyakawa Y; Sasaki T; Nakashima H; Ito M
Microbiol Immunol; 1995; 39(12):987-93. PubMed ID: 8789058
[TBL] [Abstract][Full Text] [Related]
37. Altered constitutive and stress-regulated heat shock protein 27 expression in HIV type 1-infected cell lines.
Brenner BG; Tao Y; Pearson E; Remer I; Wainberg MA
AIDS Res Hum Retroviruses; 1995 Jun; 11(6):713-7. PubMed ID: 7576931
[No Abstract] [Full Text] [Related]
38. CD4 expression decrease by antisense oligonucleotides: inhibition of rat T CD4+ cell reactivity.
Rabanal M; Franch A; Noé V; Pelegrí C; Ciudad CJ; Castellote C; Castell M
Oligonucleotides; 2003; 13(4):217-28. PubMed ID: 15000837
[TBL] [Abstract][Full Text] [Related]
39. Maleylated human serum albumin inhibits HIV-1 infection in vitro.
Takami M; Sone T; Mizumoto K; Kino K; Tsunoo H
Biochim Biophys Acta; 1992 Dec; 1180(2):180-6. PubMed ID: 1281431
[TBL] [Abstract][Full Text] [Related]
40. New CD4(+) cell line susceptible to infection by HIV-1.
Tremblay M; Sullivan AK; Rooke R; Geleziunas R; Tsoukas C; Shematek G; Gilmore N; Wainberg MA
J Med Virol; 1989 Aug; 28(4):243-9. PubMed ID: 2570823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
